Sep 09,2015

Investment by UNIC Technologies CEO Dr. Zhongxi Zheng for 5.06% of MEDITE Cancer Diagnostics, Inc. Highlights Digital Cancer Diagnostic Strategy

MEDITE Cancer Diagnostics, Inc., (OTCQB: MDIT) specializing in the development, manufacturing, and marketing of immuno-assays and premium medical devices for detection, risk assessment and diagnosis of cancer and precancerous conditions, announces an investment by UNIC Medical, Inc.'s Chairman and UNIC Technologies, Inc.’s CEO, Dr. Zhongxi Zheng, an MD in Pathology. His investment represents 5.06% of MEDITE’s outstanding common shares after the investment. In exchange for Dr. Zheng’s $1.738 million investment, MEDITE Cancer Diagnostics, Inc. issued 1,086,250 shares of unregistered common stock at the per share price of $1.60. These shares are exempt from registration under Regulation S of the Securities Act of 1933.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 02,2014

Cartagenia Closes $5.9M (€4.25M) Financing Round

Cartagenia, the leading provider of clinical-grade solutions for genomic assay interpretation and lab reporting to diagnostic genetics labs, clinicians and hospitals, today announced the closing of a $5.9 million (€4.25 million) financing round. The financing was subscribed by Cartagenia's existing shareholders and management. Shareholders include Capricorn ICT Arkiv, a Leuven-based ICT fund focussing on Digital Healthcare and Big Data, the Flemish investment company PMV and Gemma Frisius Fund, the venture fund of the University of Leuve. Cartagenia currently serves more than 120 labs and clinics across North America, Europe and Australia with its Bench Lab™ platform.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 10,2019

Omada Health receives strategic investment from Intermountain Ventures

Digital chronic disease management company Omada Health has added onto June’s $73 million funding round with a new strategic investment from Intermountain Ventures. The terms of the deal were not disclosed.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 02,2017

Fruit Street Health raises $3 million in doctors-only round

Fruit Street Health, a digital health and telemedicine company currently focused on delivering a digital diabetes prevention program, has raised $3 million in new funding from physician investors. Dr. Jeremy Tucker, a senior emergency medicine physician on the board of directors of Fruit Street, led the round, which brings the company's total funding to $8.4 million.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
May 10,2016

Humana makes strategic investment in connected diabetes management company Livongo

Livongo, the mobile-enabled diabetes management company, has raised a strategic investment from Humana to support the company’s growth. Update: Humana invested $5 million in Livongo.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Sep 12,2016

Sanofi, Verily invest $500M in diabetes management joint venture Onduo

Verily Life Sciences , a division of Google parent company Alphabet, has teamed up with French healthcare company Sanofi to launch Onduo, a diabetes-focused collaboration that leverages Sanofi’s pharmaceutical expertise and Verily’s command of miniaturized electronics, analytics and consumer software development. The two companies together invested about $500 million in Onduo. The joint venture is based in Cambridge, Massachusetts and will combine a mix of devices, software, medicine and professional care to help people with diabetes manage their condition.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 24,2016

NovioSense, a Dutch company developing a smartphone-connected tear-based glucose sensor that sits in the lower eyelid, secured an undisclosed amount of new funding

First off, NovioSense, a Dutch company developing a smartphone-connected tear-based glucose sensor that sits in the lower eyelid, secured an undisclosed amount of new funding. The round included existing investors Health Innovations, Topfonds Gelderland, Fraunhofer Ventures and NovioTech along with two new US based investors.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Nov 19,2015

LabStyle Innovations Closes $2.3 Million Round of Investment From Existing Shareholders and Private Investors

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Diabetes Management Solution, today announced it has closed on an offering raising approximately $2.3 million in proceeds through the private placement of 7,648,267 shares of Common Stock and warrants to purchase 7,648,267 shares of Common Stock with existing shareholders and private investors including a member of the Company's board of directors, employees and a Dario distributor.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 04,2021

DayTwo Announces New CEO and Raises $37 Million For Expansion of Chronic Disease Solutions

David Henderson, former founding executive member of Oscar Health, has been appointed as Chief Executive Officer of DayTwo. He joins to further scale the company and expand solutions for employers, health plans, and health systems. DayTwo also announced $37 million in new funding to accelerate its expansion of chronic disease interventions.

FUNDING FUNDING ROUND
View Analyst & Ambassador Comments
Go to original news
Subscribe to FUNDING ROUND